Business Description
This fund puts at least 90% of its money into stocks that make up a Nasdaq index tracking biotechnology and pharmaceutical companies. The index weighs holdings by market size, with some adjustments, and can include companies of all sizes. The fund concentrates its holdings rather than spreading them broadly across many different investments.